Gender Doctors In Blue States Pulled Back On Prescribing Transition Medications to Minors in 2023
According to a new analysis of medical-claims data by Do No Harm, all but one of the 24 states where pediatric gender-transition treatment remains legal saw a downturn in such prescriptions in 2023.
Pediatric gender medicine is in a nationwide retreat.
Gender clinics pulled back on prescribing gender-transition treatments to minors in 2023 in all but one of the 24 states, plus Washington, DC, that have not passed bans on such medical interventions.
This is according to comprehensive data released on Tuesday by Do No Harm. As I reported that day, the nonprofit, which opposes the use of puberty blockers and cross-sex hormones to treat gender dysphoria in minors, conducted a comprehensive analysis of medical-claims data to assess trends in such prescriptions. They also assessed trends in gender-transition surgeries in minors.
Do No Harm released their findings, which cover 2019 to 2023, in a new website: DoesMyHospitalTransitionKids.com.
The estimates are conservative, suggesting that the true numbers of minors receiving these medical interventions are greater than the web site indicates. The data set excludes medical claims that were processed internally through V…
Keep reading with a 7-day free trial
Subscribe to Hazard Ratio: Benjamin Ryan to keep reading this post and get 7 days of free access to the full post archives.